INHIBITION OF THE SALMONELLA-TYPHI ORAL VACCINE STRAIN, TY21A, BY MEFLOQUINE AND CHLOROQUINE

被引：16
作者：
HOROWITZ, H [1 ]
CARBONARO, CA [1 ]
机构：
[1] WESTCHESTER CTY MED CTR,DEPT MED,DIV INFECT DIS & IMMUNOL,VALHALLA,NY 10595
来源：
JOURNAL OF INFECTIOUS DISEASES | 1992年 / 166卷 / 06期
关键词：
D O I：
10.1093/infdis/166.6.1462-b
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1462 / 1464
页数：3
相关论文
共 10 条
[1]  
CHUTTANI CS, 1977, B WORLD HEALTH ORGAN, V55, P643
[2]  
CRYZ S J JR, 1988, Drugs of Today, V24, P349
[3]   COMPARATIVE EFFICACY OF 2, 3, OR 4 DOSES OF TY21A LIVE ORAL TYPHOID VACCINE IN ENTERIC-COATED CAPSULES - A FIELD TRIAL IN AN ENDEMIC AREA [J].
FERRECCIO, C ;
LEVINE, MM ;
RODRIGUEZ, H ;
CONTRERAS, R .
JOURNAL OF INFECTIOUS DISEASES, 1989, 159 (04) :766-769
[4]   THE HUMAN HUMORAL IMMUNE-RESPONSE TO SALMONELLA-TYPHI TY21A [J].
FORREST, BD ;
LABROOY, JT ;
BEYER, L ;
DEARLOVE, CE ;
SHEARMAN, DJC .
JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (02) :336-345
[5]   EVALUATION OF A UDP-GLUCOSE-4-EPIMERASELESS MUTANT OF SALMONELLA-TYPHI AS A LIVE ORAL VACCINE [J].
GILMAN, RH ;
HORNICK, RB ;
WOODWARD, WE ;
DUPONT, HL ;
SNYDER, MJ ;
LEVINE, MM ;
LIBONATI, JP .
JOURNAL OF INFECTIOUS DISEASES, 1977, 136 (06) :717-723
[6]   CLINICAL PHARMACOKINETICS OF MEFLOQUINE [J].
KARBWANG, J ;
WHITE, NJ .
CLINICAL PHARMACOKINETICS, 1990, 19 (04) :264-279
[7]  
LEVINE MM, 1987, LANCET, V1, P1049
[8]  
LEVINE MM, 1990, LANCET, V336, P891
[9]   ANTIBODY-RESPONSE TO PREEXPOSURE HUMAN DIPLOID-CELL RABIES VACCINE GIVEN CONCURRENTLY WITH CHLOROQUINE [J].
PAPPAIOANOU, M ;
FISHBEIN, DB ;
DREESEN, DW ;
SCHWARTZ, IK ;
CAMPBELL, GH ;
SUMNER, JW ;
PATCHEN, LC ;
BROWN, WJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (05) :280-284
[10]   ORAL IMMUNIZATION AGAINST TYPHOID-FEVER IN INDONESIA WITH TY21A VACCINE [J].
SIMANJUNTAK, CH ;
PALEOLOGO, FP ;
PUNJABI, NH ;
DARMOWIGOTO, R ;
TOTOSUDIRJO, SH ;
HARYANTO, P ;
SUPRIJANTO, E ;
WITHAM, ND ;
HOFFMAN, SL .
LANCET, 1991, 338 (8774) :1055-1059
1